SPSB1 and Sepsis: The inhibition of TGF‐β/TβRII‐Akt‐Myogenin signalling by SPSB1 may shed light on the pathogenesis of the perturbed regenerative capacity observed in muscle of critically ill patients with sepsis (Figure S19).